Weisen's 'Weimed Endo' Supplied to National Hospitals

Waycen announced on the 13th that it has been selected for the Public Procurement Service's 2nd Innovative Product Pilot Usage Project and will supply the artificial intelligence (AI) gastrointestinal endoscope 'WAYMED Endo' to three national hospitals.

Foreign medical staff are using Weisen's artificial intelligence (AI) digestive endoscope 'Weimed Endo'.
[Photo by Weisen]

This follows the Public Procurement Service's announcement on the 11th, selecting 113 institutions to pilot 59 innovative products worth 9.9 billion KRW to revitalize the domestic biohealth industry, and publishing the results on the Innovation Market.

Through this project, Waycen will supply the AI gastrointestinal endoscope WAYMED Endo to three national hospitals: Gangwon-do Gangneung Medical Center, National Health Insurance Service Ilsan Hospital, and Korea Veterans Health Service Central Veterans Hospital, thereby securing references in national hospitals. Notably, all three hospitals will implement the endoscope not just partially but throughout their entire endoscopy departments, indicating a significant scale.

Waycen has been steadily expanding its customer base by supplying this product to numerous domestic hospitals, and by supplying it to these three public hospitals, it is expected to gain momentum in sales not only in private hospitals but also in public hospitals.

WAYMED Endo is a medical AI software that analyzes stomach and colonoscopy images in real-time to detect abnormal lesions and provide disease probability. Recently, it secured the Ministry of Food and Drug Safety's Class 3 approval as the first domestic AI gastrointestinal endoscope. It is attracting high interest from hospitals and screening centers because it can be integrated with existing endoscopic equipment to introduce AI technology.

Kim Kyung-nam, CEO of Waycen, said, “We consider it a golden opportunity that Waycen’s medical AI product will be supplied to three national hospitals,” and added, “Since the Public Procurement Service has provided a great opportunity for the growth of the domestic biohealth industry, we will make the most of this chance to ensure that medical AI products rapidly spread and settle within national hospitals.”

This content was produced with the assistance of AI translation services.